RENE RAMIREZ-ORTIZ, MD
Ph.D. Medical Genetics in SAN JUAN, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: RENE RAMIREZ-ORTIZ, MD filed 1,408 Medicare Part D claims in 2023 across SAN JUAN, Puerto Rico. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
RENE RAMIREZ-ORTIZ, MD at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Ph.D. Medical Genetics compares to other specialties among Puerto Rico providers
Ph.D. Medical Genetics share within Puerto Rico
Ph.D. Medical Genetics is one of the more visible NUCC categories in Puerto Rico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Ph.D. Medical Genetics (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Ph.D. Medical Genetics ABMS/AOA estimate
Est. board-certified rate (Ph.D. Medical Genetics) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Ph.D. Medical Genetics US NPIs
Specialty board-certified rate — Ph.D. Medical Genetics estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RENE RAMIREZ-ORTIZ, MD is a Ph.D. Medical Genetics provider practicing in SAN JUAN, Puerto Rico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1679582415. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RENE RAMIREZ-ORTIZ, MD appears in the CMS NPPES registry as a Ph.D. Medical Genetics provider holding MD credentials at 369 CALLE DE DIEGO STE 304, SAN JUAN, PR, 00923, with a listed phone of (787) 250-7577. NPI 1679582415 was issued on 08/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAMIREZ-ORTIZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,408 prescription claims written by this provider, covering 201 Medicare beneficiaries and totaling roughly $526K in drug spend, split 63% brand-name and 37% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Ph.D. Medical Genetics is a narrow specialty nationwide, with 357 enrolled providers across 46 states and an average of 984 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679582415 |
|---|---|
| Specialty | Ph.D. Medical Genetics |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/07/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RENE RAMIREZ-ORTIZ, MD's current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RENE RAMIREZ-ORTIZ, MD. Source: openpaymentsdata.cms.gov.
Total received
$210
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
63% brand-name claims vs 37% generic, on 1,408 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,476
- Total Day Supply
- 40,715
- Brand vs Generic
- 63% brand / 37% generic
- Brand Drug Cost
- $379K
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 2.21
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 29, 65-74: 94, 75-84: 56, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 232 |
| Symbicort Budesonide/Formoterol Fumarate | 147 |
| Breo Ellipta Fluticasone/Vilanterol | 145 |
| Spiriva Respimat Tiotropium Bromide | 110 |
| Fluticasone Propionate | 103 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 90 |
| Montelukast Sodium | 81 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 69 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 40 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ph.D. Medical Genetics Overview
How RENE RAMIREZ-ORTIZ, MD fits within the Ph.D. Medical Genetics landscape nationally.
RENE RAMIREZ-ORTIZ, MD's 1,408 claims are above the specialty average of 984.
Nearby Ph.D. Medical Genetics Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as RAMIREZ-ORTIZ.
Compare Ph.D. Medical Genetics nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is RENE RAMIREZ-ORTIZ, MD's specialty? ▼
How much does RENE RAMIREZ-ORTIZ, MD prescribe under Medicare Part D? ▼
Where is RENE RAMIREZ-ORTIZ, MD located? ▼
What is RENE RAMIREZ-ORTIZ, MD's NPI number? ▼
Does RENE RAMIREZ-ORTIZ, MD prescribe more brand-name or generic drugs? ▼
How many Ph.D. Medical Genetics providers are there in the US? ▼
What drugs does RENE RAMIREZ-ORTIZ, MD prescribe most often? ▼
Does RENE RAMIREZ-ORTIZ, MD accept Medicare? ▼
How can I verify RENE RAMIREZ-ORTIZ, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology